Quotient Sciences has access to scale-up and pilot plant assets that complement our on-site facilities, featuring a capacity range between 50 L and 1300 L capable of producing 5-100 kg in batch. Our internal manufacturing assets (batch, CSTR, trickle bed, and plug flow) range from multi-gram to multi-kilogram capacity (multi-tonne per annum capability).
We can meet drug substance requirements from pre-clinical through to full-scale commercial phases. The scale-up process is executed by a highly experienced manufacturing team, providing customers with a secure source of supply for technically challenging projects.
Additionally, our investment in innovative, flexible modular manufacturing technology enables us to quickly configure reactors for drug substance (API) manufacturing, then rapidly reassemble reactors for the next project.